Sperm aneuploidies after human recombinant follicle stimulating hormone therapy in infertile males

Author： Piomboni Paola Serafini Francesca Gambera Laura Musacchio Concetta Collodel Giulia Morgante Giuseppe De Leo Vincenzo

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.18, Iss.5, 2009-05, pp. : 622-629

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant human follicle-stimulating hormone: a controversial issue – without controversy

By Shoham Zeev

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone: a scientific step to clinical improvement

By Hugues J-N

Reproductive BioMedicine Online, Vol. 2, Iss. 1, 2001-01 ,pp. : 54-64

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Economic Evaluation of a Recombinant Follicle-Stimulating Hormone (Follitropin Beta, Puregon) in Infertile Women Undergoing In Vitro Fertilisation in Greece

By van Loon J.

Clinical Drug Investigation, Vol. 19, Iss. 3, 2000-03 ,pp. : 201-211

Adis International

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone: gold standard or not?

By Out Henk J

Reproductive BioMedicine Online, Vol. 11, Iss. 5, 2005-11 ,pp. : 536-539

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome

By Balasch J Fábregues F Casamitjana R Peñarrubia J Vanrell JA

Reproductive BioMedicine Online, Vol. 6, Iss. 3, 2003-04 ,pp. : 296-301

Reproductive Healthcare Ltd

Access to resources Recommend Favorite